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Introduction 
World-wide, our contemporary health crisis involves the popularity of foods that 
cause both toxicity and nutrient deficiencies. Usually we think of sugar, trans-fats, 
and artificial ingredients as central culprits. Yet, one of the most potent toxins that 
people regularly ingest is naturally occurring oxalic acid and its oxalate salts. In the 
body, food-borne oxalates not only generate direct toxicity, they also deplete 
nutrients. This commentary argues for increased awareness of oxalates in foods and 
cautions against promotion of and regular use of foods high in oxalate.  
Oxalic Acid, Oxalates, and Calcium Oxalate Crystals 
Oxalic acid is a small 2-carbon molecule (formula C2H2O4) that readily donates 
protons thus forming oxalate ions (C2O42-) and oxalate salts. Being a chelating 
agent for metal cations, it forms soluble salts with the metal ions lithium (Li), 
sodium (Na), and potassium (K), and with ferrous salts. All other oxalates (notably 
calcium oxalate) are virtually insoluble at neutral or alkaline pH.  
Soluble oxalate and oxalate ions are universally toxic to mammals and 
easily move across membranes1–3. Purified forms have caused rapid deaths 
(typically accidental) since the early 1800s4,5. Being hard to detect, even at doses 
that rapidly kill a person, oxalic acid was the poison of interest in the very first 
experimental toxicology study published in 1823 in England by Robert Christison 
and Charles Coindet6.  
Free-form oxalate ions, soluble oxalate salts, insoluble oxalates, and 
mineralized calcium oxalate crystals occur naturally in plants, including food 
plants, in varying concentrations. Oxalate is also produced in the body in small 
quantities as a metabolic by-product. A group of rare genetic conditions, the 
primary hyperoxalurias (PH), causes over-production of oxalate internally with 
deadly consequences7. 
A diet with a preponderance of foods containing substantial oxalate has long 
been known to be dangerous, and sometimes deadly8. Oxalate in foods, including 
rhubarb9–12, star fruit13–15, and sorrel16 has been cited as the proximal cause of 
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human deaths many times. Non-lethal oxalate toxicity is less recognized beyond 
the growing problem of kidney stones17.  
Toxic Mechanical Injury Due to Calcium Oxalate Crystals in Plants 
The insoluble calcium oxalate crystals in plants come in a wide array of sizes and 
shapes, including bundles of double pointed needles called raphides18. These 
calcium oxalate crystals are relatively stable minerals serving as durable 
microfossils of some archaeological interest, being found where other plant 
residues are no longer evident19.  
Raphides are known to cause skin irritation, and oral and upper respiratory 
injury20. The non-food plant, Dieffenbachia, is a long-recognized and dramatic 
example. Excellent photographic illustration of oral and upper respiratory damage 
is offered in a recent report of a poisoning case requiring a 9-day hospitalization 
due to injuries sustained from brief exposure to a drop of Dieffenbachia sap21. 
Dieffenbachia possesses a system described as a defensive ‘microscopic blowgun’ 
whereby the tightly bundled raphides are forcefully ejected (assisted by turgor 
pressure of cell contents) for a distance of two to three cell lengths when the cells 
are disrupted. The “Needle Effect” of raphides has been demonstrated countless 
times, whereby traumatic injury results from the release of the raphides combined 
with the effects of proteases, soluble oxalate, and other chemical toxins carried on 
their surfaces and in their grooves in a defensive synergism22. 
In many plants, including many that we eat, calcium oxalate crystals are 
present, although there is limited research on the specific forms and quantities of 
these crystals in foods. Hard and sharp-edged, oxalate crystals take many forms, in 
varying sizes, beyond the raphide23–26. They have the potential to inflict mechanical 
injury to skin20, teeth27, and the mucosal linings of the alimentary canal28. These 
crystals may play an unrecognized role in the etiology of gut-associated illness. 
This type of localized oxalate toxicity involves mechanical abrasion and does not 
depend on absorption into the body. 
Oxalates are a likely contributor to many modern health problems  
Unlike the larger microcrystals of calcium oxalate, ionic, soluble and nano-crystal 
forms of oxalate are readily absorbed into the body29, however, a number of 
dynamic factors influence relative bio-availability30,31. A 2013 report of a study 
using radioisotope-labeled oxalate in rats by Susan Marengo, et al., demonstrated 
that “doses of oxalate typically considered unimportant have the potential to impact 
patient health” (p. 464)32. These studies and others29,33,34 show that the typical 
amounts of oxalate in our diets can easily contribute to oxalate accumulation in 
non-renal tissues even though the kidneys are healthy and their handling capacity 
is not exceeded.  
The formation of oxalate micro-crystals is especially common in human 
thyroid gland and breast tissue35,36. A study of 182 normal thyroids found that 
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eighty-five percent of people over age 50 have calcium oxalate crystals in their 
thyroid gland37. This pathology has not been explained. Bio-accumulation in 
humans probably reflects the ubiquity of excessive oxalate in normal diets38–40. 
Oxalate has also been noted to cause pathological calcification41–43, weakened 
bones44–46 and connective tissue47–49, tooth mobility50–54, and interfere with tissue 
healing55 and promote fibrosis41,56.  
Regardless of accumulation in the body, exposure to ionic oxalate has 
deleterious effects, including loss of calcium and electrolyte imbalances57. 
Castellaro, et al. (2015) demonstrated that chronic exposure of ionic oxalate alters 
breast cells, transforming normal breast cells to tumor cells58. Many case studies 
also note oxalate-induced central nervous system dysfunction without evidence of 
micro-crystal accumulation in the brain59. Oxalate toxicity is associated with 
damage to the function and structure of nerves6,60–63. 
Oxalate ions and nano-crystals are increasingly implicated as a cause or 
aggravator of a wide range of metabolic derangements associated with chronic 
health issues64–66. Dramatic increases in calcium-oxalate kidney stones, and 
functional problems with digestive health49, neurotoxicity59,61,67–69 (sleep, brain 
function), inflammation48,70–74 (chronic pain, autoimmunity, cellular stress, fatigue, 
arthritis), and connective tissue instability46,73,75,76 (osteoporosis, vulnerability to 
injury) are all consistent with increased oxalate toxicity43,77,78. Yet, these conditions 
(in tandem with the epidemic of insulin resistance and obesity) have led people to 
select foods purported to be healthier, many of which are high in oxalate.  
Healthy food promotion, “superfoods” and lost seasonality  
Modern dietary approaches, especially the “real food” movement (which includes 
ancestral health, Paleo, and vegetarian approaches) has placed great emphasis on 
the health benefits of vegetables, nuts, and spices. Without attention paid either to 
nutrient bioavailability or naturally occurring toxic substances, these approaches 
rank foods based on assumptions that all ingested nutrients are useful to the body, 
which is a dubious approach to healthy food selection79,80. 
Worse still, many foods with the highest oxalate content have risen to the 
noble status of “superfoods”, including: spinach, almonds (and most nuts), beets 
and swiss chard, blackberries81,82, potatoes and sweet potatoes, tea, chocolate, 
cinnamon, and turmeric83 (see Table 1). These items are increasingly available and 
celebrated as healthy ingredients, even in processed and convenience packaged 
foods. These high-oxalate foods are now promoted through a global food system in 
which seasons and even seasonal pricing have been erased in the retail marketplace.  
The availability of high oxalate foods we see today is unprecedented. Fresh 
spinach and almond-based milk-alternative beverages, for example, are now in 
most markets everywhere, most every day of the year. An informal survey of the 
grocery market place (both in national chains and in local health food stores) easily 
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demonstrates the proliferation of the availability of new formulations of staple 
foods and snack foods containing high oxalate ingredients.  
This combination of “lost seasonality” and the growing popularity of neo-
health food ingredients is especially dangerous with respect to oxalate consumption 
and the risk of toxicity. In this regard, the risk of harm from dietary oxalate may be 
more prevalent than at any other time in human history. 
Academic papers suggest that consumption of oxalate typically falls into a 
narrow range of 100—150 or 100—200 mg daily84–87. These results tend to be 
based on small convenience samples. The authors do not describe dietary specifics, 
do not question the data or methods from which these estimates were derived, and 
do not discuss how these estimates may or may not be generalizable to other 
populations. These ranges also do not reflect the current food trends popularizing 
foods rich in oxalate. Estimating narrow ranges is unlikely to be useful in any case, 
as intake varies widely and we lack quality data supporting specific estimates.   
Definitive, blanket statements about average oxalate intake belies both the 
variability and the idiosyncratic nature of food choices that can result in extremely 
high oxalate diets (either typically or periodically). The assumption of a steady 
oxalate intake level overlooks the dangers associated with the occasional ingestion 
of high-oxalate foods. Even a sporadic high oxalate meal (such as a spinach salad) 
can result in the growth of oxalate kidney stones88, and non-renal oxalate deposits 
as well32. Overlooking the impact of brief spikes in oxalate intake has masked the 
magnitude of the risks posed by dietary oxalate88. 
Foods Containing Oxalate and Alternative Foods 
Table 1 offers an incomplete, introductory listing of popular foods that are 
especially high in oxalate81,82,84,89–102. Legumes, grains, fruits, and several 
seasonings (including black pepper82) are omitted for simplicity, though many of 
those also contain relatively high concentrations.  
Despite crude advice often given to kidney stone patients to avoid all greens, 
there are many leafy greens that have low concentrations of oxalates (see Table 
2)82,91,92,94,94,94,95,100,102,103. There is no benefit to a blanket prohibition on greens, 
especially because this over-simplified myth obscures the oxalate content of other 
foods such as spices97, chocolate89,94, whole grains97, potatoes91,93,94, kiwi82, figs97, 
and blackberries82. 
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Table 2. Low 
Oxalate Greens 
Arugula 
Bok Choy 
Belgian Endive 
Cabbage 
Lettuce 
Mâche (Corn Salad) 
Mustard Greens 
Watercress 
 
Modern Practices Increase Our Exposure and Susceptibility 
Though humans have encountered and eaten high-oxalate foods for millennia, 
consuming them in quantity on a daily basis threatens to overwhelm our body’s 
ability to handle them without tissue damage, overt toxicity, and bioaccumulation. 
The continuous consumption we see today fails to offer time off when the body can 
expel accumulated oxalate, principally via the urine. The body may secondarily 
shunt oxalate to the colon especially when the kidneys can no longer handle the 
oxalate load and when the commensal bacterium Oxalobacter formigenes is 
present104. 
Ubiquitous overuse of antibiotics105, food additives (especially emulsifying 
agents that act like detergents in the gut, scrubbing away protective mucus106), over-
consumption of oxalate itself107, and other factors (known and unknown) have 
dramatically altered our gut microbiome and caused chronic intestinal 
inflammation in many people. The resulting changes in bacterial species and 
endothelial health in the human colon may increase absorption of oxalate and 
diminish our ability to excrete oxalate108. And, the chronic intestinal inflammation 
allows for higher rates of oxalate absorption into the body, which occurs by simple 
diffusion109,110. Another modern assault to gut health, bariatric surgery, has created 
a new and growing class of people with special susceptibility to oxalates due also 
to increased absorption111–113. Gastrointestinal lipase-inhibiting weight-loss drugs, 
especially Orlistat, also increase oxalate absorption114. 
Our kidneys naturally have an impressive but limited capacity to excrete 
oxalates. Modernity poses threats to our kidney health through the hazards of drug- 
and toxin-induced kidney damage115, and the overconsumption of sugar-sweetened 
soda116,117 and fructose118–120; sub-par intake of potassium121–123 and calcium124; and 
insulin resistance125 and the dietary and lifestyle conditions that lead up to it. 
Oxalate itself is a major source of kidney damage that makes it easier for oxalate to 
get stuck in the kidney causing a vicious cycle126–128. Renal damage, regardless of 
Table 1.  High-Oxalate Foods Commonly  
Used by Health-Informed Public 
Vegetables Nuts and Seeds “Superfoods” 
Beets 
Okra 
Plantain 
Potato 
Spinach 
Swiss chard 
Sweet Potato 
Rhubarb 
Almonds 
Cashews 
Chia 
Peanuts 
Pine nuts 
Poppy seeds 
Sesame 
 
Carob 
Chocolate; Cocoa  
Cinnamon 
Cumin 
Black Tea  
Green Tea 
Turmeric 
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the cause, lowers the efficiency of oxalate excretion and increases the likelihood of 
both renal and non-renal tissue damage from oxalate129. 
Bioaccumulation of Oxalate 
One study using 50 gm of plain chocolate containing 55 gm of oxalate130 (about 
65% soluble94) demonstrated that an ordinary dose of dietary oxalate, although 
transient, can “trigger” a 235% increase in oxalate excretion, to levels found in PH 
cases. This level of exposure is enough to incite temporary renal “failure” and 
establish oxalate deposits in renal34,131 and in non-renal tissues alike32,33. This 
occurs even when plasma oxalate values are within the normal range and kidney 
function is good. Oxalates are known to collect at sites of inflammation132 and 
injury133 where they delay healing or cause further damage. Attachment at sites of 
injured, inactive, stagnant tissue evades cellular clearance mechanisms, allowing 
minute deposits to grow and serve as sites of ongoing accumulation, owing to semi-
continuous occurrence of oxalate in body fluids. 
Yet, oxalate sequestered in tissues likely retains the potential to be released 
later (by liposomal digestion, in non-alkaline tissues) when oxalate consumption 
goes down134,135. But in today’s food market, neither a “low-oxalate season” nor 
times of food scarcity have been seen in many decades. Under these conditions, cell 
damage may be inevitable and especially in connective tissues. 
Symptoms of Oxalate Toxicity 
Oxalates can trigger inflammasome reactions that may confuse our immune 
systems and lead to autoimmunity78,136,137. They impair bone health138,139 as well as 
neurological68,140, cardiovascular41–43, and kidney function12,141,142.  
The symptoms of oxalate toxicity can be very hard to identify primarily 
because the patterns vary in idiosyncratic ways from person to person7. They are 
often subtle, typically affect multiple body systems, and often flare up 
unpredictably and irregularly—perhaps as the body tries to let go of them. These 
symptoms are common and non-specific (GI distress, headaches, joint and back 
pain) and can be vague (including generalized malaise, low energy, frequent 
urination). Because objective tests of urine141 and tissue biopsy37 are unreliable, 
oxalate-related symptoms go unrecognized as such. Despite several recent medical 
case reports that faulted the consumption of peanuts8,142,143, green juices8 and 
smoothies144, tea145, nuts and nut butter146, cashews147, and a weight loss diet 
consisting of spinach, kale, berries, and nuts148 for kidney failure in patients, 
oxalates remain obscure compounds of no special concern in modern health care. 
Historical Diagnosis 
We didn’t always ignore this problem. Oxalate-induced whole-body illness was a 
recognized, although debated, condition in the 19th and early 20th centuries, known 
to be associated with diet and manifesting with digestive, neurological, and 
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rheumatic problems149. In the 5th edition of his famous 1857 textbook, Urinary 
Deposits, Golding Bird stated “… we are told… that oxalate of lime is of constant 
occurrence, and of no importance. A remark to which too many sufferers from this 
diathesis can give a melancholy denial.” —5th ed., (1857), p. 217150  
But, like the perpetual elusiveness of the remedy for kidney stones, 
associating non-renal oxalate toxicity with objective clinical tests of body fluids 
(especially urine) remained unsolvable. Thus, the idea of non-renal oxalate toxicity, 
especially when kidney function appears normal, was essentially dismissed. As a 
result, deeper investigations of case reports or direct experiments on humans are far 
too few and often flawed.  
In the late 1800s and early 1900s, dietary intervention was recognized as an 
effective treatment for a constellation of symptoms associated with rhubarb season 
or with poor oxalate metabolism. The early knowledge has slipped into obscurity, 
awaiting rediscovery by a funding- and fad-driven research environment and a 
medical paradigm that in the early 20th Century decisively decomposed the human 
body into isolated body parts and systems. In the nutrition sciences, especially in 
epidemiology, preconceived cultural notions dominate and limit the questions 
researchers are willing to investigate. For example, toxicology data on naturally 
occurring plant toxins is very limited. As toxicologist Gerrit Speijers puts it: 
 
“Perhaps the hesitation to imply the safety aspects of inherent plant 
toxins in the agricultural research on plant breeding, fed by the fear 
that important and valuable plant foods would become a perceived 
health risk, has also contributed to the backlog in knowledge of the 
inherent plant toxins.” —Speijers (1995), p. 22479. 
Side-Stepping the Trigger/Maintenance Processes with Diet 
Once the body is retaining oxalates, lowering oxalate intake consistently to the 
expected average intake of around 100-150 mg per day may not be enough to 
reverse the damage, although research in this area is lacking. Vermeulen’s Trigger 
and Maintenance theory131 and many anecdotal reports (and the very definition of 
a low oxalate diet) indicate that intake must go below this “maintenance” exposure 
to a level that permits the destabilization and clearance of deposits and eventual 
tissue recovery. This trigger/maintenance response suggests that controlling and 
reversing oxalate toxicity in people who have become “accumulators” requires 
lowering oxalate levels in the diet to under ~60 milligrams a day. For reference, a 
half cup of cooked spinach contains several hundred milligrams of oxalate (330 – 
520 mg)82,90,94.  
There are many therapeutic and preventive benefits of avoiding dietary 
oxalates, including improvements in kidney function87,88,146,151–154. In addition, both 
published and unpublished reports suggest benefits such as reversal of 
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neurotoxicity (brain fog, cognition, behavioral and mood disorders, and sleep 
improvements155), recovery of connective tissue stability89,156 and reduced 
symptoms of autoimmunity136. 
However, with improved kidney function, tissue stores of oxalate can be 
mobilized (as has been observed after kidney transplants in primary hyperoxaluria 
(PH) patients157,158 and in the symptoms reported by thousands of low oxalate 
dieters without PH155). Even when tissue clearance of oxalate from the body 
provokes on-going periodic elevated oxalate excretion, improved kidney function 
is evident153,154. 
The safety of the oxalate release process depends, in part, on the rate of 
release not exceeding the body’s alkaline buffering capacity and kidney tolerance. 
Even when within metabolic capacity, periodic elevated circulating oxalate is likely 
to cause temporary symptom “flare-ups” with the potential to damage kidneys, the 
vascular system and other tissues during “clean-out” phases. There is also some 
evidence among PH patients that events such as surgery/surgical recovery49, 
lithotripsy159, and giving birth160 may mobilize oxalate from previously quiescent 
internal deposits161,162. Similarly, acute oxalate nephropathy has followed non-renal 
organ transplantation in patients with cystic fibrosis.163  
The reversal of oxalate accumulation in cases of dietary hyperoxaluria has 
never been formally monitored. Among PH patients, the time required for 
resolution of hyperoxaluria following liver and kidney transplantation varies 
widely. Tissues continue to release oxalate for a minimum of three years157 and 
may carry on for well beyond seven years162. Data is limited due to the small 
number of PH patients, poor survival rates, and lack of long-term follow-up 
testing. However, these lengthy release periods are consistent with reports from 
individuals who have systematically followed a long-term low-oxalate diet155. 
Reactions to the low oxalate diet are varied, from simple symptom relief, to 
serious side-effects in some cases155. An abrupt shift from a high oxalate intake to 
a low oxalate intake may be ill-advised due to the potential for excessive 
mobilization155. 
Awareness Lacking 
Biomedical researchers, clinicians, and the public health workforce have virtually 
no awareness of the threat of biological toxicity posed by over-exposure to oxalate. 
As a result, oxalate in plants (as well as other natural toxins) are overlooked as a 
potential problem associated with a number of popular foods. Ignorance of oxalate 
toxicity may pose an enormous, hidden, and growing threat to public health.  
Unfortunately, neither dietary professionals nor the consuming public are 
aware of the presence or dangers of oxalates in familiar and trusted foods. Even 
lists of oxalate content from the USDA and major universities offer very incomplete 
data that is riddled with errors89,164. 
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Encouragement of consumption of high-oxalate foods could lead to 
increased morbidity, not less as is claimed and desired. This is because the potential 
to ingest and absorb “trigger” doses and consistently eat “maintenance” doses can 
lead to a growing body burden of oxalate as well as constant exposure to ionic 
oxalate. The action we must take is to stop poisoning ourselves165. It makes no 
difference if the toxin is a man-made poison or one of nature’s poisons. A single 
toxin interfering with the function of the connective tissue, immune system, nerves, 
glands, digestion and elimination deserves our attention80. 
Conclusion 
Despite the prevailing message that there is no upper safety limit for plant food 
consumption, not all vegetables and seeds are healthy and safe to eat on a regular 
basis, as toxicological studies and many case reports have proven. Sub-lethal 
exposure to oxalate contributes to disease, although we typically overlook the non-
lethal effects and the non-renal effects166.  
The basic logic of biology tells us that the two biggest drivers of illness are 
toxicity and deficiency. Regular and repeated exposure to a toxic substance is 
harmful. Plants are inherently toxic; even food plants retain varying degrees of 
toxicity. However, this notion is foreign to the general public and health 
professionals alike.  
In today’s bifurcated food world dominated by sugary, nutrient-poor 
convenience foods opposed by super-charged “health” foods featuring high-oxalate 
ingredients, the overall health outlook remains ominous. The promotion of high 
oxalate foods is likely to have the opposite of the intended effect. Rather than 
making us healthier, the superfood craze could be, not unlike the holy war against 
saturated fat, launching another public health calamity, as expensive and unpleasant 
as the current diabetes and obesity explosion. Those of us promoting healthy eating 
owe it to ourselves, and to those we hope to help, to get informed about oxalate 
toxicity, and to embrace dietary strategies that enable us to avoid and ultimately 
recover from it. 
 
“From a practical point of view, it would be better to avoid oxalate-
rich foods […], especially when other sources of green vegetables 
are available.” —Hoover and Karunairatnam (1945)57 
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